Novavax (NVAX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $10.30 +0.78%
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $6.3 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- MSC Industrial names Rob Kuhns as executive VP and CFO
- BMO Capital Reiterates Outperform Rating on NVIDIA (NVDA)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
